Persistence of cardiovascular risk factors in women with previous preeclampsia: A long-term follow-up study

Journal of Investigative Medicine

Volumn 63, Issue 4, 2015, Pages 641-645

  Aykas, Fatma ^a   Solak, Yalcin ^b   Erden, Abdulsamet ^a   Bulut, Kadir ^a   Dogan, Selcuk ^a   Sarli, Bahadr ^a   Acmaz, Gokhan ^a   Afsar, Baris ^c   Siriopol, Dimitrie ^d   Covic, Adrian ^d   Sharma, Shailendra ^e   Johnson, Richard J ^e   Kanbay, Mehmet ^f  

^a Kayseri Training and Research Hospital ^*  (Turkey)

^b SAKARYA UNIVERSITY   (Turkey)

^c Konya Numune State Hospital   (Turkey)

^d GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f KOÇ UNIVERSITY   (Turkey)

Author keywords

cardiovascular disease; endothelial dysfunction; microalbuminuria; preeclampsia; risk factor; uric acid

Indexed keywords

URIC ACID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MEDICAL HISTORY; MICROALBUMINURIA; OBSERVATIONAL STUDY; PREECLAMPSIA; PREGNANCY; URIC ACID BLOOD LEVEL; ALBUMINURIA; BLOOD; CARDIOVASCULAR DISEASES; PRE-ECLAMPSIA; RISK FACTOR; TIME FACTOR; TRENDS; YOUNG ADULT;

ADULT; ALBUMINURIA; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; TIME FACTORS; URIC ACID; YOUNG ADULT;

EID: 84926224595     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1097/JIM.0000000000000189     Document Type: Article

References (27)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130-137.
2. Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
3. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918-930.
4. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011; 123(11):1243-1262.
5. Breetveld N, Ghossein-Doha C, van Kuijk S, et al. Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women. BJOG. 2014 Aug 20. [Epub ahead of print].
6. Ahmed R, Dunford J, Mehran R, et al. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014; 63(18):1815-1822.
7. McDonald SD, Ray J, Teo K, et al. Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis. 2013;229(1):234-239.
8. Kanbay M, SegalM,Afsar B, et al. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99:759-766.
9. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group.. Am J Obstet Gynecol. 1997;177(5): 1003-1010.
10. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013 31(10):1925-1938.
11. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
12. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93-111.
13. Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1-19.
14. Ray JG, Vermeulen MJ, Schull MJ, et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797-1803.
15. Drost JT, Arpaci G, Ottervanger JP, et al. Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM). Eur J Prev Cardiol. 2012;19(5):1138-1144.
16. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-2869.
17. Yinon Y, Kingdom JC, Odutayo A, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation. 2010;122(18):1846-1853.
18. Sandvik MK, Leirgul E, Nygard O, et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol. 2013; 209(6):569e1-569e10.
19. Chambers JC, Fusi L, Malik IS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285(12):1607-1612.
20. Wang Y, Bao X. Effects of uric acid on endothelial dysfunction in early chronic kidney disease and its mechanisms. Eur J Med Res. 2013;18:26.
21. Cnossen JS, de Ruyter-Hanhijarvi H, van der Post JA, et al. Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review. Acta Obstet Gynecol Scand. 2006;85(5):519-525.
22. Martin AC, Brown MA. Could uric acid have a pathogenic role in pre-eclampsia? Nat Rev Nephrol. 2010;6(12):744-748.
23. Noyes AM, Eckardt K. Microalbuminuria as a risk factor for cardiovascular disease in healthy individuals: a case report and review of the literature. Conn Med. 2013;77(7):399-402.
24. McDonald SD, Han Z, Walsh MW, et al. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis. 2010;55(6):1026-1039.
25. Sandvik MK, Hallan S, Svarstad E, et al. Preeclampsia and prevalence of microalbuminuria 10 years later. Clin J Am Soc Nephrol. 2013;8(7): 1126-1134.
26. Stergiotou I, Crispi F, Valenzuela-Alcaraz B, et al. Patterns of maternal vascular remodeling and responsiveness in early-versus late-onset preeclampsia. Am J Obstet Gynecol. 2013;209(6):558.e1-558.e14.
27. Akhter T, Wikstrom AK, Larsson M, et al. Individual common carotid artery wall layer dimensions, but not carotid intima-media thickness, indicate increased cardiovascular risk in women with preeclampsia: an investigation using noninvasive high-frequency ultrasound. Circ Cardiovasc Imaging. 2013;6(5):762-768.